Company News

Authorization given to add Rapigen’s COVID-19 Ag Home Test device to the MOH approved list New Zealand

Date 2022.03.16 Hit 705

The BIOCREDIT COVID-19 Ag Home Test met the selection criteria and was forwarded for full evaluation by Science and Technical Advisory.

Upon full evaluation, the BIOCREDIT COVID-19 Ag Home Test was
recommended for import, supply and/or use in Aotearoa New Zealand. This recommendation was then approved and authorization was given by the Director-General of Health on 15 March 2022. 

We appreciate your patience and continued interest in supporting Rapigen.